Phase I, Randomized, Controlled, Observer-Blind, Dose-Ranging Study of Acellular Pertussis and Tetanus-Diptheria-Acellular Pertussis Booster Vaccine in Adults Ages 18 to 40 Years.
Phase of Trial: Phase I
Latest Information Update: 06 Apr 2016
At a glance
- Drugs Pertussis acellular vaccine (Primary) ; DTaP vaccine
- Indications Diphtheria; Pertussis; Tetanus
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Novartis Vaccines
- 01 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 02 Jul 2012 Planned end date changed from 1 May 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.